These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30520240)

  • 1. Targeted Feature Extraction in MALDI Mass Spectrometry Imaging to Discriminate Proteomic Profiles of Breast and Ovarian Cancer.
    Cordero Hernandez Y; Boskamp T; Casadonte R; Hauberg-Lotte L; Oetjen J; Lachmund D; Peter A; Trede D; Kriegsmann K; Kriegsmann M; Kriegsmann J; Maass P
    Proteomics Clin Appl; 2019 Jan; 13(1):e1700168. PubMed ID: 30520240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Class Prediction Model to Discriminate Pancreatic Ductal Adenocarcinoma from Pancreatic Neuroendocrine Tumor by MALDI Mass Spectrometry Imaging.
    Casadonte R; Kriegsmann M; Perren A; Baretton G; Deininger SO; Kriegsmann K; Welsch T; Pilarsky C; Kriegsmann J
    Proteomics Clin Appl; 2019 Jan; 13(1):e1800046. PubMed ID: 30548962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-to-Site Reproducibility and Spatial Resolution in MALDI-MSI of Peptides from Formalin-Fixed Paraffin-Embedded Samples.
    Ly A; Longuespée R; Casadonte R; Wandernoth P; Schwamborn K; Bollwein C; Marsching C; Kriegsmann K; Hopf C; Weichert W; Kriegsmann J; Schirmacher P; Kriegsmann M; Deininger SO
    Proteomics Clin Appl; 2019 Jan; 13(1):e1800029. PubMed ID: 30408343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MALDI-Imaging for Classification of Epithelial Ovarian Cancer Histotypes from a Tissue Microarray Using Machine Learning Methods.
    Klein O; Kanter F; Kulbe H; Jank P; Denkert C; Nebrich G; Schmitt WD; Wu Z; Kunze CA; Sehouli J; Darb-Esfahani S; Braicu I; Lellmann J; Thiele H; Taube ET
    Proteomics Clin Appl; 2019 Jan; 13(1):e1700181. PubMed ID: 30471200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new classification method for MALDI imaging mass spectrometry data acquired on formalin-fixed paraffin-embedded tissue samples.
    Boskamp T; Lachmund D; Oetjen J; Cordero Hernandez Y; Trede D; Maass P; Casadonte R; Kriegsmann J; Warth A; Dienemann H; Weichert W; Kriegsmann M
    Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):916-926. PubMed ID: 27836618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Suitable is Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight for Metabolite Imaging from Clinical Formalin-Fixed and Paraffin-Embedded Tissue Samples in Comparison to Matrix-Assisted Laser Desorption/Ionization-Fourier Transform Ion Cyclotron Resonance Mass Spectrometry?
    Buck A; Balluff B; Voss A; Langer R; Zitzelsberger H; Aichler M; Walch A
    Anal Chem; 2016 May; 88(10):5281-9. PubMed ID: 27065343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) identifies proteomic differences in breast-cancer-associated stroma.
    Dekker TJ; Balluff BD; Jones EA; Schöne CD; Schmitt M; Aubele M; Kroep JR; Smit VT; Tollenaar RA; Mesker WE; Walch A; McDonnell LA
    J Proteome Res; 2014 Nov; 13(11):4730-8. PubMed ID: 24762205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging mass spectrometry to discriminate breast from pancreatic cancer metastasis in formalin-fixed paraffin-embedded tissues.
    Casadonte R; Kriegsmann M; Zweynert F; Friedrich K; Baretton G; Otto M; Deininger SO; Paape R; Belau E; Suckau D; Aust D; Pilarsky C; Kriegsmann J
    Proteomics; 2014 Apr; 14(7-8):956-64. PubMed ID: 24482424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MALDI Imaging for Proteomic Painting of Heterogeneous Tissue Structures.
    Kriegsmann J; Kriegsmann M; Kriegsmann K; Longuespée R; Deininger SO; Casadonte R
    Proteomics Clin Appl; 2019 Jan; 13(1):e1800045. PubMed ID: 30471204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In MALDI-Mass Spectrometry Imaging on Formalin-Fixed Paraffin-Embedded Tissue Specimen Section Thickness Significantly Influences m/z Peak Intensity.
    Longuespée R; Kriegsmann K; Cremer M; Zgorzelski C; Casadonte R; Kazdal D; Kriegsmann J; Weichert W; Schwamborn K; Fresnais M; Schirmacher P; Kriegsmann M
    Proteomics Clin Appl; 2019 Jan; 13(1):e1800074. PubMed ID: 30216687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digital PCR After MALDI-Mass Spectrometry Imaging to Combine Proteomic Mapping and Identification of Activating Mutations in Pulmonary Adenocarcinoma.
    Kazdal D; Longuespée R; Dietz S; Casadonte R; Schwamborn K; Volckmar AL; Kriegsmann J; Kriegsmann K; Fresnais M; Stenzinger A; Sültmann H; Warth A; Kriegsmann M
    Proteomics Clin Appl; 2019 Jan; 13(1):e1800034. PubMed ID: 30216696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detergent addition to tryptic digests and ion mobility separation prior to MS/MS improves peptide yield and protein identification for in situ proteomic investigation of frozen and formalin-fixed paraffin-embedded adenocarcinoma tissue sections.
    Djidja MC; Francese S; Loadman PM; Sutton CW; Scriven P; Claude E; Snel MF; Franck J; Salzet M; Clench MR
    Proteomics; 2009 May; 9(10):2750-63. PubMed ID: 19405023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular profiles of thyroid cancer subtypes: Classification based on features of tissue revealed by mass spectrometry imaging.
    Pietrowska M; Diehl HC; Mrukwa G; Kalinowska-Herok M; Gawin M; Chekan M; Elm J; Drazek G; Krawczyk A; Lange D; Meyer HE; Polanska J; Henkel C; Widlak P
    Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):837-845. PubMed ID: 27760391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Proteomic Markers in Head and Neck Cancer Using MALDI-MS Imaging, LC-MS/MS, and Immunohistochemistry.
    Hoffmann F; Umbreit C; Krüger T; Pelzel D; Ernst G; Kniemeyer O; Guntinas-Lichius O; Berndt A; von Eggeling F
    Proteomics Clin Appl; 2019 Jan; 13(1):e1700173. PubMed ID: 30411850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues.
    De Sio G; Smith AJ; Galli M; Garancini M; Chinello C; Bono F; Pagni F; Magni F
    Mol Biosyst; 2015 Jun; 11(6):1507-14. PubMed ID: 25592401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptic peptide reference data sets for MALDI imaging mass spectrometry on formalin-fixed ovarian cancer tissues.
    Meding S; Martin K; Gustafsson OJ; Eddes JS; Hack S; Oehler MK; Hoffmann P
    J Proteome Res; 2013 Jan; 12(1):308-15. PubMed ID: 23214983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter Evaluation of Tissue Classification by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging.
    Deininger SO; Bollwein C; Casadonte R; Wandernoth P; Gonçalves JPL; Kriegsmann K; Kriegsmann M; Boskamp T; Kriegsmann J; Weichert W; Schirmacher P; Ly A; Schwamborn K
    Anal Chem; 2022 Jun; 94(23):8194-8201. PubMed ID: 35658398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MALDI Imaging Combined with Laser Microdissection-Based Microproteomics for Protein Identification: Application to Intratumor Heterogeneity Studies.
    Longuespée R; Alberts D; Baiwir D; Mazzucchelli G; Smargiasso N; De Pauw E
    Methods Mol Biol; 2018; 1788():297-312. PubMed ID: 29224050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mass spectrometry imaging technology and its application in breast cancer research].
    Zhang M; Zhang Y; Wang H; Li N; Li B; Xiao H; Bian W; Cai Z
    Se Pu; 2021 Jun; 39(6):578-587. PubMed ID: 34227318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visualizing Energy Charge in Breast Carcinoma Tissues by MALDI Mass-spectrometry Imaging Profiles of Low-molecular-weight Metabolites.
    Torata N; Kubo M; Miura D; Ohuchida K; Mizuuchi Y; Fujimura Y; Hayakawa E; Kai M; Oda Y; Mizumoto K; Hashizume M; Nakamura M
    Anticancer Res; 2018 Jul; 38(7):4267-4272. PubMed ID: 29970560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.